Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CAMPBELL & CO INVESTMENT ADVISER LLC | 05-09-2023 | 03-31-2023 | 780 | 536,676,889 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Avantax Inc | Common Stock | 1601 | $322,788 | 12,264 | 0.00 | 12,264 | +Inf | 03-31-2023 | |
Ligand Pharmaceuticals Inc | Common Stock | 1602 | $321,972 | 4,377 | 0.00 | 0.00 | -797 | -15.40 | 03-31-2023 |
Darling Ingredients Inc | Common Stock | 1603 | $321,901 | 5,512 | 0.00 | 5,512 | +Inf | 03-31-2023 | |
Qiagen NV | Common Stock | 1604 | $321,510 | 7,000 | 0.00 | 0.00 | 823 | 13.32 | 03-31-2023 |